Upcoming Login Downtime
We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.
For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Astraveus S.A.S.
BioCentury | Nov 29, 2023
Management Tracks
Camille Bedrosian named Amylyx CMO
Plus: Cameron Turtle becomes CEO of Spyre, and updates from Ocuphire and Astraveus
BioCentury | Aug 31, 2023
Management Tracks
Oxford Science Enterprises names new CEO, first CIO
Plus: Frías hired as CMO at Biomea Fusion, and updates from Astraveus and Septerna
BioCentury | Jun 27, 2023
Product Development
June 27 Quick Takes: FDA denies Regeneron’s high-dose Eylea
Plus: Sanofi meets in atopic dermatitis and updates from Nkarta, Astraveus and more
Items per page:
1 - 3 of 3